Literature DB >> 23803034

Association of ABO blood group and risk of lung cancer in a multicenter study in Turkey.

Yuksel Urun1, Gungor Utkan, Ayten Kayi Cangir, Omur Berna Oksuzoglu, Nuriye Ozdemir, Derya Gokmen Oztuna, Gokhan Kocaman, Hasan Şenol Coşkun, Muhammet Ali Kaplan, Cabir Yuksel, Ahmet Demirkazik, Fikri Icli.   

Abstract

BACKGROUND: The ABO blood groups and Rh factor may affect the risk of lung cancer.
MATERIALS AND METHODS: We analyzed 2,044 lung cancer patients with serologically confirmed ABO/Rh blood group. A group of 3,022,883 healthy blood donors of Turkish Red Crescent was identified as a control group. We compared the distributions of ABO/Rh blood group between them.
RESULTS: The median age was 62 years (range: 17-90). There was a clear male predominance (84% vs. 16%). Overall distributions of ABO blood groups were significantly different between patients and controls (p=0.01). There were also significant differences between patients and controls with respect to Rh positive vs. Rh negative (p=0.04) and O vs. non-O (p=0.002). There were no statistically significant differences of blood groups with respect to sex, age, or histology.
CONCLUSIONS: In the study population, ABO blood types were associated with the lung cancer. Having non-O blood type and Rh-negative feature increased the risk of lung cancer. However, further prospective studies are necessary to define the mechanisms by which ABO blood type may influence the lung cancer risk.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23803034     DOI: 10.7314/apjcp.2013.14.5.2801

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

1.  Glioblastoma and ABO blood groups: further evidence of an association between the distribution of blood group antigens and brain tumours.

Authors:  Mohammed Z Allouh; Mohammed M Al Barbarawi; Mohammad Y Hiasat; Mohammed A Al-Qaralleh; Emad I Ababneh
Journal:  Blood Transfus       Date:  2016-06-30       Impact factor: 3.443

2.  Association of ABO blood groups with von Willebrand factor, factor VIII and ADAMTS-13 in patients with lung cancer.

Authors:  Xia Liu; Xiaogang Chen; Jiezuan Yang; Renyong Guo
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

3.  Modeling the Spatial Distribution of Cancer and Determining the Associated Risk Factors.

Authors:  Lijalem Melie Tesfaw; Essey Kebede Muluneh
Journal:  Cancer Inform       Date:  2020-07-29

Review 4.  Hemostasis, cancer, and ABO blood group: the most recent evidence of association.

Authors:  Giancarlo Maria Liumbruno; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

Review 5.  The role of the histoblood ABO group in cancer.

Authors:  Seth K Rummel; Rachel E Ellsworth
Journal:  Future Sci OA       Date:  2016-03-15

6.  ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer.

Authors:  Céline Montavon Sartorius; Andreas Schoetzau; Henriette Kettelhack; Daniel Fink; Neville F Hacker; André Fedier; Francis Jacob; Viola Heinzelmann-Schwarz
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

7.  The ABO Blood Group is an Independent Prognostic Factor in Patients with Ovarian Cancer.

Authors:  Qian Song; Jun-Zhou Wu; Sheng Wang; Zhong-Bo Chen
Journal:  J Cancer       Date:  2019-10-22       Impact factor: 4.207

8.  The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer.

Authors:  Koichi Fukumoto; Tetsuo Taniguchi; Noriyasu Usami; Koji Kawaguchi; Takayuki Fukui; Futoshi Ishiguro; Shota Nakamura; Kohei Yokoi
Journal:  J Epidemiol       Date:  2014-12-06       Impact factor: 3.211

9.  Epidemiologic characteristics of oral cancer: single-center analysis of 4097 patients from the Sun Yat-sen University Cancer Center.

Authors:  Ji Zhang; Fan Gao; An-Kui Yang; Wen-Kuan Chen; Shu-Wei Chen; Huan Li; Xing Zhang; Zhong-Yuan Yang; Xin-Lin Chen; Ming Song
Journal:  Chin J Cancer       Date:  2016-03-03

10.  The Prevalence of Rhesus-Negative Blood Group Among Patient With Small Cell Lung Cancer and Analysis of Its Effect on Overall Survival.

Authors:  Abhishek Biswas; Yue Jiang; Danmeng Li; Hiren J Mehta; Frederic Kaye
Journal:  Front Oncol       Date:  2018-09-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.